# Kim M. Hirshfield

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/kim-m-hirshfield/

## Facts

| Field | Value |
| --- | --- |
| Citations | 3,404 |
| Field | Cancer Genomics and Diagnostics |
| h-index | 28 |
| i10-index | 49 |
| Last Known Institution | Merck & Co., Inc., Rahway, NJ, USA (United States) |
| OpenAlex ID | https://openalex.org/A5018754593 |
| ORCID iD | 0000-0002-5848-1316 |
| Works | 143 |

## Researcher papers

- [Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer](https://scholariq.org/papers/immune-activation-and-response-to-pembrolizumab-in-pole-mutant-endometrial/)
- [MDM2 SNP309 Accelerates Tumor Formation in a Gender-Specific and Hormone-Dependent Manner](https://scholariq.org/papers/mdm2-snp309-accelerates-tumor-formation-in-a-gender-specific-and-hormone/)
- [Contribution of serine, folate and glycine metabolism to the ATP, NADPH and purine requirements of cancer cells](https://scholariq.org/papers/contribution-of-serine-folate-and-glycine-metabolism-to-the-atp-nadph-and-purine/)
- [Molecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and Treatment](https://scholariq.org/papers/molecular-characterization-of-epithelial-ovarian-cancer-implications-for/)
- [Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer](https://scholariq.org/papers/immune-activation-and-benefit-from-avelumab-in-ebv-positive-gastric-cancer/)
- [The metabolic demands of cancer cells are coupled to their size and protein synthesis rates](https://scholariq.org/papers/the-metabolic-demands-of-cancer-cells-are-coupled-to-their-size-and-protein/)
- [RET rearrangements are actionable alterations in breast cancer](https://scholariq.org/papers/ret-rearrangements-are-actionable-alterations-in-breast-cancer/)
- [Detection of clonal hematopoiesis of indeterminate potential in clinical sequencing of solid tumor specimens](https://scholariq.org/papers/detection-of-clonal-hematopoiesis-of-indeterminate-potential-in-clinical/)
- [Serum Biomarkers for the Detection of Cardiac Toxicity after Chemotherapy and Radiation Therapy in Breast Cancer Patients](https://scholariq.org/papers/serum-biomarkers-for-the-detection-of-cardiac-toxicity-after-chemotherapy-and/)
- [Impact of Preexisting Mental Illness on All-Cause and Breast Cancer–Specific Mortality in Elderly Patients With Breast Cancer](https://scholariq.org/papers/impact-of-preexisting-mental-illness-on-all-cause-and-breast-cancer-specific/)
- [Real-world perioperative treatment patterns and economic burden of recurrence in early-stage HER2-negative breast cancer: a SEER-Medicare study](https://scholariq.org/papers/real-world-perioperative-treatment-patterns-and-economic-burden-of-recurrence-in/)

## Researcher topics

- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Cancer-related Molecular Pathways](https://scholariq.org/topics/cancer-related-molecular-pathways/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Researcher university

- [Merck & Co., Inc., Rahway, NJ, USA (United States)](https://scholariq.org/institutions/merck-and-co-inc-rahway-nj-usa-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.